Dragonfly Therapeutics, Inc

Call

Website

180 3rd Ave Ste 600

Waltham, MA 02451

+1 (617) 588-0086

https://www.dragonflytx.com

Dragonfly Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA. They are dedicated to discovering, developing, and commercializing innovative therapies that leverage the body's innate immune system to deliver groundbreaking treatments for patients. With a robust pipeline of clinical and preclinical candidates, Dragonfly utilizes its proprietary platform to identify novel drug candidates in collaboration with industry leaders such as Bristol Myers Squibb, Merck, and Abbvie.

Led by a highly experienced Clinical Leadership Team, Dragonfly Therapeutics is focused on advancing their deep pipeline of therapeutic agents in various disease areas, including immuno-oncology, oncology, and immunology. Their team brings extensive expertise in drug development, regulatory affairs, and drug safety strategy, ensuring the successful progression of multiple novel drug candidates into clinical trials. Committed to making a significant impact in the field of medicine, Dragonfly Therapeutics aims to bring breakthrough treatments to patients by harnessing the power of the body's immune system.

Generated from the website

Own this business?

See a problem?

Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Obsidian Therapeutics

Frontera Therapeutics is a leading clinical-stage biotechnology company based in Bedford, Town of, MA. They specialize in developing innovative gene therapy medicines to enhance the lives of patients across various disease areas. Frontera's APEX Technology Manufacturing Platform utilizes advanced adeno-associated virus (AAV) gene expression systems, clinically validated AAV vectors, and efficient CMC processes to expedite the development of novel gene therapy products with lower costs and faster speed-to-market. With a world-class team and state-of-the-art GMP facilities, Frontera is focused on addressing not only rare monogenic disorders but also larger patient markets including Ophthalmology, Hematology, Cardiovascular, and Metabolic Diseases.Generated from the website

Biotechnical research, commercial, Real estate managers

Obsidian Therapeutics Inc

Obsidian Therapeutics Inc, based in Cambridge, MA, is at the forefront of precision cell and gene therapy, utilizing its proprietary cytoDRIVE platform to engineer regulated therapeutic proteins. The company is dedicated to pioneering the next generation of engineered therapeutics to address critical patient needs. With a focus on innovative solutions, Obsidian is advancing its lead clinical program, OBX115, an engineered TIL cell therapy targeting advanced melanoma. The company’s commitment to collaboration and urgency drives its mission to improve patient outcomes through cutting-edge science and technology. Generated from the website

United States›Massachusetts›Waltham›Dragonfly Therapeutics, Inc

Dragonfly Therapeutics, Inc

You might also like